AI assistant
Jazz Pharmaceuticals plc — Director's Dealing 2015
Aug 11, 2015
30751_dirs_2015-08-11_03e78148-1bc3-4dd6-b847-484d495ed619.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-08-07
Reporting Person: ENRIGHT PATRICK G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-07 | Ordinary Shares | A | 1310 | $0.00 | Acquired | 2960 | Direct |
| 2015-08-10 | Ordinary Shares | S | 797 | $179.98 | Disposed | 2163 | Direct |
| 2015-08-10 | Ordinary Shares | S | 4 | $183.36 | Disposed | 2159 | Direct |
| 2015-08-10 | Ordinary Shares | S | 196 | $180.05 | Disposed | 284108 | Indirect |
| 2015-08-10 | Ordinary Shares | S | 7362 | $181.71 | Disposed | 276746 | Indirect |
| 2015-08-10 | Ordinary Shares | S | 1177 | $182.68 | Disposed | 275569 | Indirect |
| 2015-08-10 | Ordinary Shares | S | 1069 | $183.77 | Disposed | 274500 | Indirect |
| 2015-08-10 | Ordinary Shares | S | 4 | $180.05 | Disposed | 5692 | Indirect |
| 2015-08-10 | Ordinary Shares | S | 148 | $181.71 | Disposed | 5544 | Indirect |
| 2015-08-10 | Ordinary Shares | S | 23 | $182.69 | Disposed | 5521 | Indirect |
| 2015-08-10 | Ordinary Shares | S | 21 | $183.75 | Disposed | 5500 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-08-07 | Nonstatutory Stock Option (right to buy) | $181.79 | A | 3415 | Acquired | 2025-08-06 | Ordinary Shares (3415) | Direct |
Footnotes
F1: These restricted stock units are granted pursuant to the Issuer's 2007 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 30, 2016.
F2: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F3: Sale effected pursuant to a Rule 10b5-1 trading plan.
F4: The Reporting Person is a managing member of Longitude Capital Partners, LLC, the general partner of each of Longitude Venture Partners, L.P. and Longitude
Capital Associates, L.P. The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture Partners, L.P. and Longitude
Capital Associates, L.P. except to the extent of his pecuniary interest therein.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.33 to $182.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.35 to $183.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.45 to $184.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.45 to $184.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F9: This option is granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. Subject to the Reporting Person's continuous service and certain additional conditions, this option vests in 12 equal monthly installments beginning on August 1, 2015.